Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis

Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

NCT01578811 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

NCT03184402 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

NCT03024086 ·Status: COMPLETED ·Phase: PHASE3

The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology

NCT04029441 ·Status: UNKNOWN

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

NCT03437785 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

NCT02567578 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

NCT01817556 ·Status: COMPLETED ·Phase: PHASE4

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

NCT02112214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?

NCT00284700 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis

NCT06948487 ·Status: RECRUITING

Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients

NCT04296513 ·Status: COMPLETED

Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

NCT01002443 ·Status: COMPLETED ·Phase: PHASE2

Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients

NCT05786807 ·Status: UNKNOWN ·Phase: PHASE4

The GAstric Precancerous Conditions Study

NCT04191551 ·Status: RECRUITING

Serum Pepsinogen After H. Pylori Eradication

NCT03924375 ·Status: COMPLETED

Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea

NCT02184910 ·Status: UNKNOWN

Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients

NCT02691637 ·Status: COMPLETED

Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists

NCT04984382 ·Status: UNKNOWN ·Phase: NA

Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

NCT04403087 ·Status: COMPLETED ·Phase: PHASE4

A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection

NCT02806674 ·Status: UNKNOWN ·Phase: NA

Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms

NCT07272681 ·Status: NOT_YET_RECRUITING

Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia

NCT00990405 ·Status: UNKNOWN ·Phase: PHASE4

Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection

NCT01643785 ·Status: TERMINATED ·Phase: NA

To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

NCT06668506 ·Status: COMPLETED

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

NCT02407119 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3